Cardlytics (CDLX) Tops Q2 EPS by 49c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.24), $0.49 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $76.7 million versus the consensus estimate of $69.11 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance